Alnylam Pharmaceuticals, Inc.
GNAQ targeted dsRNA compositions and methods for inhibiting expression

Abstract:

The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a G-alpha q subunit (GNAQ) of a heterotrimeric G gene, and methods of using the dsRNA to inhibit expression of GNAQ.